SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis

Linzhang Huang1, Ken L Chambliss1, Xiaofei Gao2,3,4,5

  • 1Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Nature
|April 26, 2019
PubMed

Insights

Scavenger receptor SR-B1 in endothelial cells actively transports LDL cholesterol into artery walls, promoting atherosclerosis. This finding challenges passive LDL entry and suggests new therapeutic targets for cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Cell Biology
  • Atherosclerosis Research

Background:

  • Atherosclerosis, a major cause of heart attack and stroke, begins with low-density lipoprotein (LDL) cholesterol entering artery walls.
  • The precise mechanism of LDL entry into the artery wall remains incompletely understood.

Purpose of the Study:

  • To investigate the role of scavenger receptor class B type 1 (SR-B1) in endothelial cells in mediating LDL entry into arteries.
  • To elucidate the molecular mechanisms by which SR-B1 facilitates LDL transport and promotes atherosclerosis.

Main Methods:

  • Studies in mouse models to assess SR-B1 function in endothelial cells.
  • In vivo colocalization studies of LDL and SR-B1.
  • Investigation of the interaction between SR-B1, dedicator of cytokinesis 4 (DOCK4), and RAC1 signaling.
  • Analysis of SR-B1 and DOCK4 expression in mouse and human atherosclerotic arteries.

Main Results:

  • Endothelial SR-B1 mediates LDL delivery into arteries and accumulation by macrophages, driving atherosclerosis.
  • LDL particles colocalize with SR-B1 in endothelial intracellular vesicles.
  • SR-B1-mediated LDL transcytosis requires direct binding and a specific cytoplasmic domain interacting with DOCK4, which activates RAC1.
  • SR-B1 and DOCK4 expression are upregulated in atherosclerosis-prone areas and human atherosclerotic arteries.

Conclusions:

  • Endothelial SR-B1 actively transports LDL into artery walls, challenging the passive diffusion model of atherogenesis.
  • Targeting endothelial LDL delivery via SR-B1 inhibition presents a novel therapeutic strategy for cardiovascular disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.6K
Inflammation01:38

Inflammation

Overview
61.7K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K